Appleyard, J. W., Seligmann, J. F., Morton, D., Elliott, F., Handley, K., Glimelius, B., Hemmings, G., Bottomley, D., Quirke, P., Magill, L., West, N., Beggs, A. D., Williams, C. (2026). FOxTROT: Predictive effects of
                    <i>ERBB2</i>
                    and
                    <i>ERBB3</i>
                    on neoadjuvant panitumumab benefit in
                    <i>RAS/BRAF</i>
                    wild-type (-wt) locally advanced colon cancer (LACC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.17